These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9312737)

  • 1. [Squamous carcinoma of the gallbladder. Anatomo-clinical study of a case with reference to oncogene expression].
    Botto Micca F; Coda R; Giordano F; Bona A; Bossotti M; Benedetto C
    Pathologica; 1997 Feb; 89(1):77-80. PubMed ID: 9312737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
    Haitel A; Posch B; El-Baz M; Mokhtar AA; Susani M; Ghoneim MA; Marberger M
    J Urol; 2001 May; 165(5):1481-7. PubMed ID: 11342901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 and c-erbB-2 protein expression in adenocarcinomas and epithelial dysplasias of the gall bladder.
    Kamel D; Pääkkö P; Nuorva K; Vähäkangas K; Soini Y
    J Pathol; 1993 May; 170(1):67-72. PubMed ID: 8100854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermoid carcinoma of the lip: an immunohistochemical study.
    García-Montesinos-Perea B; Val-Bernal JF; Saiz-Bustillo R
    Med Oral Patol Oral Cir Bucal; 2005; 10(5):454-61. PubMed ID: 16264381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [An early carcinoma of the gallbladder with atypical epithelium ( a report of a case with elevated p53 expression)].
    Yabar HA; Watanabe H
    Rev Gastroenterol Peru; 1994; 14(1):65-8. PubMed ID: 8018902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression of p53 in gallbladder carcinoma and in dysplastic and metaplastic lesions of the surrounding mucosa].
    Billo P; Marchegiani C; Capella C; Sessa F
    Pathologica; 2000 Aug; 92(4):249-56. PubMed ID: 11029885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An immunohistochemical comparison between low-grade and high-grade ovarian serous carcinomas: significantly higher expression of p53, MIB1, BCL2, HER-2/neu, and C-KIT in high-grade neoplasms.
    O'Neill CJ; Deavers MT; Malpica A; Foster H; McCluggage WG
    Am J Surg Pathol; 2005 Aug; 29(8):1034-41. PubMed ID: 16006797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expressions of cyclin-dependent kinase inhibitors (p27 and p21) and their relation to p53 and Ki-67 in oral squamous tumorigenesis.
    Choi HR; Tucker SA; Huang Z; Gillenwater AM; Luna MA; Batsakis JG; El-Naggar AK
    Int J Oncol; 2003 Feb; 22(2):409-14. PubMed ID: 12527941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of Ki-67 and p53 antigen expression in carcinomas of bile duct and gallbladder.
    Shrestha ML; Miyake H; Kikutsuji T; Tashiro S
    J Med Invest; 1998 Aug; 45(1-4):95-102. PubMed ID: 9864969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study of invasive squamous cell carcinoma and verrucous carcinoma of the oral cavity: expression of bcl-2, p53, and Her-2/neu, and indexes of cell turnover.
    Drachenberg CB; Blanchaert R; Ioffe OB; Ord RA; Papadimitriou JC
    Cancer Detect Prev; 1997; 21(6):483-9. PubMed ID: 9398988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prognosis value of p53, C-erB-2 and Ki67 proteins in ovarian carcinoma].
    Frutuoso C; Silva MR; Amaral N; Martins I; De Oliveira C; De Oliveira HM
    Acta Med Port; 2001; 14(3):277-83. PubMed ID: 11552325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation among six biologic factors (p53, p21(WAF1), MIB-1, EGFR, HER2, and Bcl-2) and clinical outcomes after curative chemoradiation therapy in squamous cell cervical cancer.
    Yamashita H; Murakami N; Asari T; Okuma K; Ohtomo K; Nakagawa K
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1165-72. PubMed ID: 19101092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of expression of Ki-67, EGFR, c-erbB-2, MMP-9, p53, bcl-2, CD34 and cell cycle analysis with survival in head and neck squamous cell cancer.
    Smilek P; Dusek L; Veselý K; Rottenberg J; Kostrica R
    J Exp Clin Cancer Res; 2006 Dec; 25(4):549-55. PubMed ID: 17310847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical expression of Bcl-2 protein in breast lesions: correlation with Bax, p53, Rb, C-erbB-2, EGFR and proliferation indices.
    Ioachim EE; Malamou-Mitsi V; Kamina SA; Goussia AC; Agnantis NJ
    Anticancer Res; 2000; 20(6B):4221-5. PubMed ID: 11205251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical expression of p53 and c-erbB2 proteins in breast cancer in Egypt.
    el-A Helal T; Khalifa A; Kamel AS
    Anticancer Res; 2000; 20(3B):2145-50. PubMed ID: 10928168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The detection of dysplastic lesions of the gallbladder mucosa in polypoid cholelithiasis].
    Bădescu ME; Stancu M; Pandele GI; Cozma L; Dobrescu G; Amălinei C; Grigoraş A; Bădescu A; Baran D
    Rev Med Chir Soc Med Nat Iasi; 2005; 109(1):116-9. PubMed ID: 16607838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncogene expression and microvessel count in recurrent and nonrecurrent stage Ib squamous cell carcinoma of the cervix.
    Hove MG; Dinh TV; Hannigan EV; Lucci JA; Chopra V; Smith ER; To T
    J Reprod Med; 1999 Jun; 44(6):493-6. PubMed ID: 10394542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ki-67 and p53 expression as prognosticators of clinical course aggressiveness of squamous cell cancer of the larynx].
    Gorban' NA; Ten VP; Pankratov VA
    Vopr Onkol; 2007; 53(6):668-73. PubMed ID: 18416135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Squamous cell carcinoma of the thyroid: an aggressive tumor associated with tall cell variant of papillary thyroid carcinoma.
    Kleer CG; Giordano TJ; Merino MJ
    Mod Pathol; 2000 Jul; 13(7):742-6. PubMed ID: 10912933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical localization of metallothionein in human breast cancer in comparison with cathepsin D, stromelysin-1, CD44, extracellular matrix components, P53, Rb, C-erbB-2, EGFR, steroid receptor content and proliferation.
    Ioachim E; Kamina S; Demou A; Kontostolis M; Lolis D; Agnantis NJ
    Anticancer Res; 1999; 19(3A):2133-9. PubMed ID: 10470161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.